Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces
Key facts
- Who runs it
- Centre hospitalier de l'Université de Montréal (CHUM)
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 1 Dec 2021
- Ended
- Mar 2026
- Type of study
- Interventional, 3 groups
- Treatments tested
- Femtosecond laser assisted cataract surgery with Active Sentry handpiece
- Standard phacoemulsification with the Active Sentry handpiece
- Standard phacoemulsification with the OZil handpiece
- Record updated
- 19 March 2026
- Why it stopped
- The study was withdrawn prior to participant enrollment.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Adult patient (over 18 years of age)
- Patients undergoing uncomplicated cataract surgery with intraocular lens implantation
- Ability to provide informed consent
- Ability to be followed for the entire duration of the study
Who cannot take part
- Another surgery combined with cataract extraction
- Patient with concomitant ocular diseases other than cataract (such as corneal, retinal, or glaucoma diseases)
- History of ocular surgery
- Minor patient (under 18 years of age)
- Unable to give informed consent
- Unable to be followed for the duration of the study
- Irregular corneal astigmatism or keratoconus
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main goal of this study is to compare traditional cataract surgery with two new technologies: the femtosecond laser and the new Active Sentry handpiece.
Read full original descriptionShow less
The femtosecond laser is used in several fields of ophthalmology and allows to automate multiple key steps of cataract surgery.
The new generation of handpiece called Active Sentry has the particularity to detect the pressure inside the eye in real time and to adjust it to avoid large variations.
Theses technologies would potentially increase the efficacy and safety of standard cataract surgery. This study therefore aims at evaluating the differences in cumulative dissipated energy and endothelial cell loss between femtosecond laser assisted cataract surgery with the new Active Sentry handpiece compared to standard phaco with new (Active Sentry) or older handpieces (OZil).
The 3 groups in the trial
- Femtosecond laser assisted cataract surgery with Active Sentry handpieceTreatment being tested
Participants suffering from cataract who are candidates for femtosecond laser assisted cataract surgery
- Standard phacoemulsification with the Active Sentry handpieceTreatment being tested
Participants suffering from cataract who are candidates for standard phacoemulsification with the new Active Sentry handpiece
- Standard phacoemulsification with the OZil handpieceTreatment being tested
Participants suffering from cataract who are candidates for standard phacoemulsification with the traditional OZil handpiece
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of Corneal Endothelial Cell Loss and Cumulative Dissipated Energy Between Femtosecond Laser Assisted Cataract Surgery and Standard Phacoemulsification With the Active Sentry or OZil Handpiece
- Record updated
- 19 March 2026